73 related articles for article (PubMed ID: 8191865)
1. Monocytotoxic antibodies in HIV-infected persons. TNF-alpha treatment of U937 cells increases the complement dependent cytotoxicity.
Szabó B; Locardi C; Lo Presti E; Benedetto A; Belardelli F
Acta Microbiol Hung; 1993; 40(3):191-200. PubMed ID: 8191865
[TBL] [Abstract][Full Text] [Related]
2. Tumour necrosis factor-alpha increases the sensitivity of human immunodeficiency virus (HIV)-infected monocytic U937 cells to the complement-dependent cytotoxicity of sera from HIV type 1-infected individuals; role of the gp120 protein.
Szabò B; Locardi C; Lo Presti E; Belardelli F; Benedetto A
J Gen Virol; 1993 Jul; 74 ( Pt 7)():1271-6. PubMed ID: 8336118
[TBL] [Abstract][Full Text] [Related]
3. Mannoprotein-induced anti-U937 cell cytotoxicity in peripheral blood mononuclear cells from uninfected or HIV-infected subjects: role of interferon-gamma and tumor necrosis factor-alpha.
Gomez MJ; Torosantucci A; Quinti I; Testa U; Peschle C; Cassone A
Cell Immunol; 1993 Dec; 152(2):530-43. PubMed ID: 8258154
[TBL] [Abstract][Full Text] [Related]
4. Antibody-dependent cellular cytotoxicity against HIV-coated target cells by peripheral blood monocytes from HIV seropositive asymptomatic patients.
Jewett A; Giorgi JV; Bonavida B
J Immunol; 1990 Dec; 145(12):4065-71. PubMed ID: 2258607
[TBL] [Abstract][Full Text] [Related]
5. Complement-dependent cytotoxicity of antibodies reactive with HIV-induced cell surface antigens in HIV-carrying haemophiliacs.
Tóth FD; Kiss J; Szabó B; Füst G; Ujhelyi E; Hollán SR; Váczi L
Acta Virol; 1989 Dec; 33(6):521-6. PubMed ID: 2576594
[TBL] [Abstract][Full Text] [Related]
6. Induction of IFN-alpha by HIV-1 in monocyte-enriched PBMC requires gp120-CD4 interaction but not virus replication.
Francis ML; Meltzer MS
J Immunol; 1993 Aug; 151(4):2208-16. PubMed ID: 8345204
[TBL] [Abstract][Full Text] [Related]
7. The role of complement and gp120-specific antibodies in virus lysis and CD4+ T cell depletion in HIV-1-infected patients.
Gerencer M; Burek V; Crowe BA; Barrett NP; Dorner F
Microb Pathog; 1998 Nov; 25(5):253-66. PubMed ID: 9878454
[TBL] [Abstract][Full Text] [Related]
8. Complement-activating antibodies in sera from infected individuals and vaccinated volunteers that target human immunodeficiency virus type 1 to complement receptor type 1 (CR1, CD35).
Zhou J; Montefiori DC
Virology; 1996 Dec; 226(1):13-21. PubMed ID: 8941318
[TBL] [Abstract][Full Text] [Related]
9. Are blockers of gp120/CD4 interaction effective inhibitors of HIV-1 immunopathogenesis?
Herbeuval JP; Shearer GM
AIDS Rev; 2006; 8(1):3-8. PubMed ID: 16736946
[TBL] [Abstract][Full Text] [Related]
10. A novel EGFP-CEM-NKr flow cytometric method for measuring antibody dependent cell mediated-cytotoxicity (ADCC) activity in HIV-1 infected individuals.
Kantakamalakul W; Pattanapanyasat K; Jongrakthaitae S; Assawadarachai V; Ampol S; Sutthent R
J Immunol Methods; 2006 Aug; 315(1-2):1-10. PubMed ID: 16884734
[TBL] [Abstract][Full Text] [Related]
11. Productive HHV-6 infection in differentiated U937 cells: role of TNF alpha in regulation of HHV-6.
Arena A; Liberto MC; Capozza AB; Focà A
New Microbiol; 1997 Jan; 20(1):13-20. PubMed ID: 9037664
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of resistance of HIV-1 primary isolates to complement-mediated lysis.
Takefman DM; Sullivan BL; Sha BE; Spear GT
Virology; 1998 Jul; 246(2):370-8. PubMed ID: 9657955
[TBL] [Abstract][Full Text] [Related]
13. Shared antigenic epitopes on the V3 loop of HIV-1 gp120 and proteins on activated human T cells.
Trujillo JR; Rogers RA; Brain JD
Virology; 1998 Jun; 246(1):53-62. PubMed ID: 9656993
[TBL] [Abstract][Full Text] [Related]
14. Antibodies to conserved epitopes of the HIV-1 envelope in sera from long-term non-progressors: prevalence and association with neutralizing activity.
Braibant M; Brunet S; Costagliola D; Rouzioux C; Agut H; Katinger H; Autran B; Barin F
AIDS; 2006 Oct; 20(15):1923-30. PubMed ID: 16988513
[TBL] [Abstract][Full Text] [Related]
15. Saliva can mediate HIV-1-specific antibody-dependent cell-mediated cytotoxicity.
Kim JS; Nag P; Landay AL; Alves M; Cohn MH; Bremer JW; Baum LL
FEMS Immunol Med Microbiol; 2006 Nov; 48(2):267-73. PubMed ID: 16978244
[TBL] [Abstract][Full Text] [Related]
16. Temporal development and prognostic value of antibody response to the major neutralizing epitopes of gp120 during HIV-1 infection.
Turbica I; Simon F; Besnier JM; LeJeune B; Choutet P; Goudeau A; Barin F
J Med Virol; 1997 Jul; 52(3):309-15. PubMed ID: 9210041
[TBL] [Abstract][Full Text] [Related]
17. Cellular and cytokine dependent monocyte-mediated leukemic cell death: modulation by interferon-gamma and tumor necrosis factor-alpha.
van de Loosdrecht AA; Beelen RH; Ossenkoppele GJ; Broekhoven MG; Langenhuijsen MM
Exp Hematol; 1993 Mar; 21(3):461-8. PubMed ID: 8440344
[TBL] [Abstract][Full Text] [Related]
18. Fc receptor but not complement binding is important in antibody protection against HIV.
Hessell AJ; Hangartner L; Hunter M; Havenith CE; Beurskens FJ; Bakker JM; Lanigan CM; Landucci G; Forthal DN; Parren PW; Marx PA; Burton DR
Nature; 2007 Sep; 449(7158):101-4. PubMed ID: 17805298
[TBL] [Abstract][Full Text] [Related]
19. TNF-alpha inhibits HIV-1 replication in peripheral blood monocytes and alveolar macrophages by inducing the production of RANTES and decreasing C-C chemokine receptor 5 (CCR5) expression.
Lane BR; Markovitz DM; Woodford NL; Rochford R; Strieter RM; Coffey MJ
J Immunol; 1999 Oct; 163(7):3653-61. PubMed ID: 10490959
[TBL] [Abstract][Full Text] [Related]
20. DNA vaccines expressing soluble CD4-envelope proteins fused to C3d elicit cross-reactive neutralizing antibodies to HIV-1.
Bower JF; Green TD; Ross TM
Virology; 2004 Oct; 328(2):292-300. PubMed ID: 15464849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
